Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas
暂无分享,去创建一个
R. Korn | J. Tabernero | D. V. Von Hoff | M. Moore | D. Goldstein | S. Siena | J. Van Laethem | M. Moore | L. Teixeira | F. Arena | B. Lu | D. McGovern | R. Ramanathan | Helen Liu | H. Liu | J. Laethem | D. V. Hoff | D. Mcgovern